Structures by: Satyanarayan M. N.
Total: 16
4-(4-Methylpiperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)- 7-(trifluoromethyl)quinoline
C23H20F3N5O
Acta Crystallographica Section E (2011) 67, 11 o3117-o3118
a=8.5065(15)Å b=10.2176(17)Å c=13.709(3)Å
α=103.840(5)° β=98.515(5)° γ=109.034(4)°
2-(4-Bromophenyl)-2-oxoethyl 2-methylbenzoate
C16H13BrO3
Acta Crystallographica Section E (2011) 67, 11 o3119
a=5.45190(10)Å b=31.2382(5)Å c=9.72060(10)Å
α=90.00° β=120.4100(10)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl 4-bromobenzoate
C15H10Br2O3
Acta Crystallographica Section E (2011) 67, 7 o1582-o1583
a=11.0483(3)Å b=5.90790(10)Å c=33.8550(8)Å
α=90.00° β=108.8020(10)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl 4-chlorobenzoate
C15H10BrClO3
Acta Crystallographica Section E (2011) 67, 7 o1723
a=17.1061(11)Å b=5.3062(4)Å c=24.0376(16)Å
α=90.00° β=101.5020(10)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl anthracene-9-carboxylate
C23H15BrO3
Acta Crystallographica Section E (2012) 68, 6 o1876
a=10.1906(8)Å b=15.0591(12)Å c=13.7938(8)Å
α=90.00° β=122.376(4)° γ=90.00°
2-(4-Fluorophenyl)-2-oxoethyl 2-methoxybenzoate
C16H13FO4
Acta Crystallographica Section E (2012) 68, 2 o513
a=7.9370(3)Å b=26.4456(9)Å c=7.0635(2)Å
α=90.00° β=113.4040(10)° γ=90.00°
Diethyl 2-{[2-(trifluoromethyl)anilino]methylidene}propanedioate
C15H16F3NO4
Acta Crystallographica Section E (2012) 68, 2 o514-o515
a=7.8080(2)Å b=10.1485(3)Å c=10.5265(3)Å
α=95.1930(10)° β=109.1830(10)° γ=99.4050(10)°
2-Oxo-2-phenylethyl benzoate
C15H12O3
Acta Crystallographica Section E (2011) 67, 6 o1528
a=9.0299(13)Å b=14.116(2)Å c=9.6379(14)Å
α=90.00° β=90.564(3)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl 4-methoxybenzoate
C16H13BrO4
Acta Crystallographica Section E (2011) 67, 6 o1529
a=7.9700(5)Å b=7.9852(5)Å c=11.3185(7)Å
α=86.5360(10)° β=83.2050(10)° γ=89.6330(10)°
2-(4-Chlorophenyl)-2-oxoethyl 3-(trifluoromethyl)benzoate
C16H10ClF3O3
Acta Crystallographica Section E (2011) 67, 7 o1597
a=14.3036(7)Å b=12.1335(6)Å c=8.5464(4)Å
α=90.00° β=101.4440(10)° γ=90.00°
2-(4-Chlorophenyl)-2-oxoethyl 2-methoxybenzoate
C16H13ClO4
Acta Crystallographica Section E (2011) 67, 7 o1687
a=7.7207(6)Å b=14.4411(12)Å c=26.064(2)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl 2-methoxybenzoate
C16H13BrO4
Acta Crystallographica Section E (2011) 67, 7 o1724
a=7.8424(5)Å b=14.6799(9)Å c=25.7677(14)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Chlorophenyl)-2-oxoethyl 2,4-difluorobenzoate
C15H9ClF2O3
Acta Crystallographica Section E (2011) 67, 7 o1599
a=16.0179(17)Å b=7.9609(8)Å c=24.0172(18)Å
α=90.00° β=115.939(5)° γ=90.00°
2-(4-Fluorophenyl)-2-oxoethyl 4-methoxybenzoate
C16H13FO4
Acta Crystallographica Section E (2011) 67, 12 o3456
a=9.3523(2)Å b=10.1949(2)Å c=15.6465(4)Å
α=90.00° β=118.842(2)° γ=90.00°
2-(4-Bromophenyl)-2-oxoethyl 4-methylbenzoate
C16H13BrO3
Acta Crystallographica Section E (2011) 67, 12 o3154
a=5.8368(2)Å b=8.3438(3)Å c=27.9684(8)Å
α=90.00° β=95.1770(10)° γ=90.00°
Ethyl 4-oxo-8-trifluoromethyl-1,4-dihydroquinoline-3-carboxylate
C13H10F3NO3
Acta Crystallographica Section E (2012) 68, 12 o3304-o3305
a=9.8248(3)Å b=11.0222(3)Å c=12.3450(4)Å
α=72.9340(10)° β=74.1670(10)° γ=74.0590(10)°